These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The use of corticosteroid agents in connective tissue disorders. Barraclough D. Med J Aust; 1986 Apr 14; 144(8):427-32. PubMed ID: 2870416 [No Abstract] [Full Text] [Related]
3. [Controlled clinical research on the use of ibuprofen in rheumatoid arthritis and other rheumatic diseases]. Giordano M, Tirri G, Capelli L, Gallo M, Scott GG. Minerva Med; 1973 Jun 23; 64(47):2483-90. PubMed ID: 4579840 [No Abstract] [Full Text] [Related]
4. [Azathioprine in rheumatology]. Mathies H. Fortschr Med; 1979 Dec 20; 97(48):2215-7. PubMed ID: 43824 [Abstract] [Full Text] [Related]
5. Corticosteroids: Friends and Foes. Bolster MB. Rheum Dis Clin North Am; 2016 Feb 20; 42(1):xv-xvi. PubMed ID: 26611560 [No Abstract] [Full Text] [Related]
6. [Glucocorticoids in the therapy of rheumatism. 2: Systemic corticoid therapy]. Kaiser H. Fortschr Med; 1998 Dec 10; 116(34):41-3. PubMed ID: 10024761 [No Abstract] [Full Text] [Related]
7. Adrenal steroid therapy in neurological disease. Part I. Eisen AA, Norris JW. Can Med Assoc J; 1969 Jan 04; 100(1):27-30. PubMed ID: 4388115 [No Abstract] [Full Text] [Related]
9. Immunosuppressive therapy in rheumatic disease. Pirofsky B, Bardana EJ. Med Clin North Am; 1977 Mar 04; 61(2):419-37. PubMed ID: 16187 [No Abstract] [Full Text] [Related]
10. [Therapeutic approach for systemic diseases in the elderly. Horton disease and rhizomelic pseudopolyarthritis]. Doucet J. Rev Med Interne; 2008 Dec 04; 29 Suppl 3():S289-93. PubMed ID: 18996628 [No Abstract] [Full Text] [Related]
11. [Polymyalgia rheumatica]. Szymański AF. Pol Tyg Lek; 1969 Feb 25; 24(8):288-9. PubMed ID: 4389303 [No Abstract] [Full Text] [Related]
12. [RHEUMATISM AND VASCULAR DISEASES]. LAMBERT P. Munch Med Wochenschr; 1965 Jan 01; 107():14-20. PubMed ID: 14301170 [No Abstract] [Full Text] [Related]
13. Cytotoxic drugs: their clinical application to the rheumatic diseases. Clements PJ, Davis J. Semin Arthritis Rheum; 1986 May 01; 15(4):231-54. PubMed ID: 2872726 [No Abstract] [Full Text] [Related]
14. [Current problems of immunology and immunosuppressive therapy in rheumatic diseases]. Vorlaender KO. Clin Ter; 1967 Jul 15; 42(1):3-14. PubMed ID: 4386113 [No Abstract] [Full Text] [Related]
15. [Corticosteroid therapy in modern medicine (on the 25th anniversary of the first application of cortisone)]. Sigidin IaA. Sov Med; 1974 Jul 15; 0(7):78-82. PubMed ID: 4605591 [No Abstract] [Full Text] [Related]
17. Corticosteroids for rheumatic disease. 2. Effects on disease states, effects on bone. Jamieson T. Postgrad Med; 1986 Apr 15; 79(5):247-8, 250. PubMed ID: 3485794 [No Abstract] [Full Text] [Related]
18. [Immunosuppressive agents for therapy of autoimmune diseases of the skin and of psoriasis]. Ruszczak Z. Hautarzt; 1977 Mar 15; 28(3):125-31. PubMed ID: 15957 [Abstract] [Full Text] [Related]
19. Ocular manifestations of rheumatic disorders. Natural and iatrogenic. Henkind P, Gold DH. Rheumatology; 1973 Mar 15; 4(0):13-59. PubMed ID: 4151989 [No Abstract] [Full Text] [Related]
20. [Prerequisites and first results of the therapeutic use of azathioprine (imuran) in chronic progressive rheumatic arthritis and in so-called collagen diseases]. Barnikol HU, Vorlaender KO. Med Welt; 1967 Jan 21; 3():160-9. PubMed ID: 4383822 [No Abstract] [Full Text] [Related] Page: [Next] [New Search]